Skip to main content
SpringerLink
Log in

Pharmacological Treatment of Suicidal Behavior

  • Chapter
Suicide Prevention

  • 375 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • American Psychiatric Association. Practice guideline for major depressive disorder in adults. American Journal of Psychiatry, 1993; 150(suppl.): 1–26.

    Google Scholar 

  • Asberg M, Traskman M. Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Archives of General Psychiatry, 1976; 33: 1193–1197.

    CAS  PubMed  Google Scholar 

  • Baldwin D, Bullock T, Montgomery D, Montgomery S. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behavior. International Clinical Psychophatmacology, 1991; 6(suppl.): 49–55

    Google Scholar 

  • Ballenger NC, Post RM. Carbamazepine (Tegretol) in manic-depressive illness: a new treatment. American Journal of Psychiatry, 1980; 137: 782–790.

    CAS  PubMed  Google Scholar 

  • Barraclough B. Suicide prevention, recurrent affective disorders and lithium. British Journal of Psychiatry, 1972; 121: 391–392.

    CAS  PubMed  Google Scholar 

  • Barraclough B, Bunch J, Nelson B. A hundred cases of suicide: clinical aspects. British Journal of Psychiatry, 1974; 125: 355–373.

    CAS  PubMed  Google Scholar 

  • Blumenthal SJ. Suicide: A guide to risk factors. assessment, and treatment of suicidal patients. Medical Clinics of North Anierica. 1988; 72: 937–962.

    CAS  Google Scholar 

  • Brinkley R, Beitman BD. Friedel RO. Low-dose neuroleptic regimen in the treatment of borderline patients. Archives of General Psychiatry, 1979; 36: 319–326.

    CAS  PubMed  Google Scholar 

  • Buckley NA, Dawson AH, Whyte IM, Henry DA: Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. The Lancet, 1994; 343: 159–162.

    CAS  Google Scholar 

  • Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. British Medical Journal, 1987 295: 1021–1024.

    CAS  PubMed  Google Scholar 

  • Causemann B, Muller-Oerlinghausen B. Does lithium prevent suicides and suicide attempts? In Birch (editor) Lithium: inorganic pharmacology and psychiatric use, IRL Press, Oxford. 1988.

    Google Scholar 

  • Cohen LS, Winchel RM, Stanley M. Biological markers of suicide risk and adolescent suicide. Clinical Neuropharmacology, 1988; 1I: 423–435.

    Google Scholar 

  • Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks C, et al. Long-term lithium and mortality. Lancet, 1990; 335: 1347.

    Article  CAS  PubMed  Google Scholar 

  • Cowdry RW. Gardner DL. Pharmacotherapy of borderline personality disorder. Archives of General Psychiatry, 1988: 45: I11–119.

    Google Scholar 

  • Crome P. The toxicity of drugs used for suicide. Acta Psychiatrica Scandinavica suppl, 1993: 371: 33–37.

    CAS  Google Scholar 

  • Dasgupta K, Hoover E. Additional cases of suicidal ideation associated with fluoxetine. American Journal of Psychiatry. 1990; 147: 1570–I57I.

    Google Scholar 

  • De Leo D, Marazziti D. Biological prediction of suicide: the role of serotonin. Crisis, 1988; 9: 109–118.

    PubMed  Google Scholar 

  • De Wilde J, Mertens C. Fredricson Overo K, Hepfner Peterson HE. Citalopram versus mianserin. Acta Psychiatrica Scandinavica. 1985; 72: 89–96.

    PubMed  Google Scholar 

  • Di Costanzo E, Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiatrica Scandinavica. 1991; 83: 456–459.

    PubMed  Google Scholar 

  • Ennis J. Suicide prevention. Canadian Medical Association Journal, 1983: 129: 1078.

    Google Scholar 

  • Feighner JP. The role of venlafaxine in rational antidepressant therapy. Journal of Clinical Psychiatry, 1994; 55(9, suppl A): 62–68.

    PubMed  Google Scholar 

  • Gaind R, Jacobi R. Benzodiazepines causing aggression. In Gaind, Hudson (Eds) Current Themes in Psychiatry, Publishing Company, London, 1978.

    Google Scholar 

  • Gardner DL, Cowdry RW. Alprazolam-induced dyscontrol in borderline personality disorder. American Journal of Psychiatry, 1985; 142: 98–100.

    CAS  PubMed  Google Scholar 

  • Gardner DL, Cowdry RW. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. American Journal of Psychiatry, 1986; 143: 519–522.

    CAS  PubMed  Google Scholar 

  • Gasperini M, Gatti F, Bellini L, Anniverno R, Smeraldi E. Perspectives in clinical psychopharmacology of aniitryptyline and fluvoxamine: a double-blind study in depressed inpatients. Neuropsychobiology, 1992; 26: 186–192.

    CAS  PubMed  Google Scholar 

  • Gonella G, Baignoli G, Ecari V. Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Current Medical Research and Opinion. 1990; 12: 177–184.

    CAS  PubMed  Google Scholar 

  • Guze SB, Robins E. Suicide and primary affective disorders. British Journal of Psychiatry, 1970; 117: 437–438.

    CAS  PubMed  Google Scholar 

  • Hendin H. Psychodynamics of suicide, with particular reference to the young. American Journal of Psychiatry. 1991; 148: 1150–1157.

    CAS  PubMed  Google Scholar 

  • Hoover CE. Suicidal ideation not associated with fluoxetine. American Journal of Psychiatry. 1991; 148: 543.

    CAS  PubMed  Google Scholar 

  • King RA, Riddle MA. Chappell PB. Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. Journal of American Academy of Child and Adolescent Psychiatry, 1991; 30: 179–186.

    CAS  Google Scholar 

  • Kjelsberg E, Eikeseth PH, Dahl AA. Suicide in borderline patients: predictive factors. Acta Psychiatrica Scandinavica, I991: 84: 283–287.

    Google Scholar 

  • Lipinski JF, Mallya G, Zimmerman P, Pope HG. Fluoxetine-induced akathisia: clinical and theoretical implications. Journal of Clinical Psychiatry, 1989; 50: 339–342.

    PubMed  Google Scholar 

  • Lopez-Ibor JJ jr. Reduced suicidality with paroxetine. European Psychiatry. 1993; 8(suppl. 1): 17s–19s.

    Google Scholar 

  • Lowenstein SR. Suicidal behavior: recognition and intervention. Hospital Practice, 1985; 10: 52–71.

    Google Scholar 

  • Mann JJ, Goodwin K, O’Brien C, Robinson DS. Suicidal behavior and psychotropic medication. Neuropsychophamacology, 1993; 8: 177–183.

    Google Scholar 

  • Mann JJ, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Archives of General Psychiatry. 1991: 48: 1027–1032.

    CAS  PubMed  Google Scholar 

  • Maric MM. Criteria for selection of first choice antidepressive agents. Ceskoslovenska Psychiatrica, 1992; 88: 220–224.

    CAS  Google Scholar 

  • Masand P, Gupta S, Dewan M. Suicidal ideation related to fluoxetine treatment. New England Journal of Medicine, 1991; 324: 420.

    CAS  PubMed  Google Scholar 

  • Mattes JA. Carbamazepine for uncontrolled rage outbursts. Lancet, 1984; 2: 1164–1165.

    CAS  PubMed  Google Scholar 

  • Mendelson WB. Rich CL. Sedatives and suicide: the San Diego study. Acta Psychiatrica Scandinavica, 1993; 88: 337–341.

    CAS  PubMed  Google Scholar 

  • Michel K, Arestegui G. Spuhler T. Suicide with psychotropic drugs in Switzerland. Pharmacopsychiatry, 1994; 27: 114–118.

    CAS  PubMed  Google Scholar 

  • Michel K, Waeber W, Valach L, Arestegui G, Spuhler T. A comparison of the drugs taken in fatal and nonfatal self-poisoning. Acta Psychiatrica Scandinavica, 1994; 90: 184–189.

    CAS  PubMed  Google Scholar 

  • Miles D. Conditions predisposing to suicide: a review. Journal of Nervous and Mental Diseases, 1977; 164: 231–246.

    CAS  Google Scholar 

  • Modestin J, Schwarzenbach F. Effect of psychopharmacotherapy on suicide risk in discharged psychiatric inpatients. Acta Psychiatrica Scandinavica, 1992: 85: 173–175.

    CAS  PubMed  Google Scholar 

  • Moller HJ, Fuger J, Kasper S. Efficacy of new generation antidepressants: meta-analysis of imipramine-controlled studies. Pharmacopsychiatry, 1994: 27: 215–223.

    CAS  PubMed  Google Scholar 

  • Montgomery SA. Depression in the elderly: pharmacokinetics of antidepressants and deaths from overdose. International Clinical Psychophamiacology, 1990; 5: 67–74.

    Google Scholar 

  • Montgomery SA, McAuley R, Rani SJ, Roy D, Montgomery DB. A double-blind comparison of zimelidine and amitriptyline in endogenous depression. Acta Psychiatrica Scandinavica, 198I; 290(suppl.): 314–327.

    CAS  Google Scholar 

  • Montgomery SA. Montgomery DB. Pharmacological prevention of suicidal behavior. Journal of Affective Disorders, 1982; 4: 291–298.

    Article  CAS  PubMed  Google Scholar 

  • Montgomery SA, Montgomery DB. The prevention of suicidal acts in high risk patients. In Usdin (editor) Frontiers in biochemical and pharmacological research in depression. Raven Press, New York, 1984.

    Google Scholar 

  • Montgomery SA, Montgomery DB, Rani SJ. Roy DH, Shaw PJ. Maintenance therapy in repeat suicidal behavior: a placebo-controlled trial. 10th International Congress for Suicide Prevention, Ottawa. 1979.

    Google Scholar 

  • Montgomery DB, Roberts A, Green M, Bullock T. Baldwin D, Montgomery SA. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. European Archives of Psychiatry and Clinical Neuroscience, 1994: 244: 211–215.

    Article  CAS  PubMed  Google Scholar 

  • Muijen M, Roy D, Silverstone T, Mehmet A, Christie M. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients. Acta Psychiatrica Scandinavica, 1988; 78: 384–390.

    CAS  PubMed  Google Scholar 

  • Muller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G. et al. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatrica Scandinavica, 1992; 86: 218–222.

    CAS  PubMed  Google Scholar 

  • Muller-Oerlinghausen B, Kossmann B, Volks J, Hermann H. Frequency, quality and temporal pattern of relapses during ten years of lithium prophylaxis. In Birch (editor) Lithium: inorganic pharmacology and psychiatric use, IRL Press, Oxford, 1988.

    Google Scholar 

  • Mullin JM, Pandita-Gunawardena VR, Whithead AM. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorders. British Journal of Clinical Practitioner, 1988; 42: 51–55.

    CAS  Google Scholar 

  • Murphy GE. Clinical indication of suicidal risk. Archives of General Psychiatry, 1972; 27: 356–359.

    CAS  PubMed  Google Scholar 

  • Murphy GE. The prediction of suicide: why is it so difficult? American Journal of Psychotherapy, 1984; 38: 341–349.

    CAS  PubMed  Google Scholar 

  • Murphy GE. The physician’s role in suicide prevention. In Roy (editor) Suicide, Williams & Wilkins, Baltimore, 1986.

    Google Scholar 

  • Ojehagen A, Regnell G, Trasknian-Bendz L. Deliberate self-poisoning: repeaters and nonrepeaters admitted to an intensive care unit. Acta Psychiatrica Scandinavica, 1991; 84: 266–271.

    CAS  PubMed  Google Scholar 

  • Okuma T, Inanaga K, Otsuki S. A preliminary double-blind study of the efficacy of carbamazepine in prophilaxis of manic-depressive illness. Psychopharmacology, 1981; 73: 95–96.

    Article  CAS  PubMed  Google Scholar 

  • Ottevanger EA. Fluvoxamine superior to imipramine in suicidal depressed patients. European Neuropsychophamiacology, 1993; 3(3, special issue): 362–363.

    Google Scholar 

  • Pary R, Lippmann S, Turns DM, Tobias CR. Drug selection after overdose recovery: carbamazepine or lithium. Journal of Kentucky Medical Association. 1987: 85: 21–23.

    CAS  Google Scholar 

  • Pokomy AD. Suicide rates in various psychiatric disorders. Journal of Nervous and Mental Diseases, 1964; 139: 499–506.

    Google Scholar 

  • Power AC, Cowen PJ. Fluoxetine and suicidal behaviour: some clinical and theoretical aspects of a controversy. British Joumal of Psychiatry, 1992; 161: 735–741.

    CAS  Google Scholar 

  • Preskorn SH, Burke M. Somatic therapy for major depressive disorder: selection of an antide-pressant. Journal of Clinical Psychiatry, 1992: 53(suppl.): 5–16.

    PubMed  Google Scholar 

  • Rao ML, Braunig P, Papassotiropoulos A. Autoaggressive behavior is closely related to serotonin availability in schizoaffective disorder. Pharmacopsychiatry, 1994; 27: 202–206.

    CAS  PubMed  Google Scholar 

  • Robins E, Murphy GE, Wilkinson RM. Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides. American Journal of Public Health, 1959; 49: 888–898.

    CAS  PubMed  Google Scholar 

  • Roose SP, Glassman AH, Attia E. Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. American Journal of Psychiatry, 1994; 151: 1735–1739.

    CAS  PubMed  Google Scholar 

  • Rouillon F, Phillip R, Serrurier D, Ansart E, Gerard MJ. Rechutes de depression unipolaire et efficacite de la maprotiline. Encephale. 1989: 15; 527–534.

    CAS  PubMed  Google Scholar 

  • Sacchetti E, Vita A, Guarneri L, Cornacchia M. The effectiveness of fluoxetine, clomipramine. nortriptyline and desipramine in major depressives with suicidal behaviour: preliminary findings. In Cassano. Akiskal (editors) Serotonin-related psychiatric syndromes: clinical and therapeutic links, No. 165, pp. 47–53, Royal Society of Medicine Services Limited, London, 1991.

    Google Scholar 

  • Salzmann C, Kochansky GE, Shader RI, Porrino LJ, Harmatz JS, et al. Chlordiazepoxide-induced hostility in a small group setting. Archives of General Psychiatry, 1974; 31: 401–405.

    Google Scholar 

  • Schifano F, De Leo D: Can phamiacological intervention aid in the prevention of suicidal behavior’? Pharmacopsychiatry, 1991; 24: 113–117.

    CAS  PubMed  Google Scholar 

  • Schifano F, Magni G. Corfini A. Antidepressivi e apparato cardiovascolare. Aspetti farmacologici e clinici. Quademi Italiani di Psichiatria, 1991; 10: 221–244.

    Google Scholar 

  • Schifano F. Pharmacological strategies for preventing suicidal behaviour. CNS Drugs, 1994; 1: 16–25

    Google Scholar 

  • Song F, Freemantle N, Sheldon TA, House A, Watson P, et al. Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability. Britis Medical Journal, 1993; 306: 683–686.

    CAS  Google Scholar 

  • Taiminen TJ. Effect of psychopharmacotherapy on suicide risk in psychiatric inpatients. Acta Psychiatrica Scandinavica, 1993; 87: 45–47.

    CAS  PubMed  Google Scholar 

  • Thase ME. Long-term treatment of recurrent depressive disorders. Journal of Clinical Psychiatry, 1992; 53(suppl.): 32–41.

    PubMed  Google Scholar 

  • Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 1990; 147: 207–210.

    CAS  PubMed  Google Scholar 

  • Traskman L, Asberg M, Bertilsson L, Sjostrand L. Monoamine metabolites in cerebrospinal fluid and suicidal behavior. Archives of General Psychiatry, 1981; 38: 631–636.

    CAS  PubMed  Google Scholar 

  • Van Praag HM. Psychobiology of suicidal behavior. Annals of New York Academy of Sciences, 1986; 487: 150–167.

    Google Scholar 

  • Vetro A, Pallag P. Szentistvanyl LI, Vargha M. Szilard J. Treatment of childhood aggressivity with lithium. Aggressologie, 1981; 22: 27–30.

    CAS  Google Scholar 

  • Volk J, Muller-Oerlinghausen B. Quality of interepisodic periods in patients with affective disorders under long-term lithium treatment. Pharmacopsychiatry, 1988; 21: 426–427.

    CAS  PubMed  Google Scholar 

  • Waddington D, McKenzie IP. Overdose rates in lithium-treated versus antidepressant-treated outpatients. Acta Psychiatrica Scandinavica, 1994; 90: 50–52.

    CAS  PubMed  Google Scholar 

  • Winokur A, Rickels K, Greenblatt DJ. Snyder PJ, Schatz NJ. Withdrawal reaction from longterm, low dosage administration of diazepam. Archives of General Psychiatry, 1980; 37: 101–105.

    CAS  PubMed  Google Scholar 

  • Wirshing W, Van Putten T, Rosenberg J. Marder S, Ames D, et al. Fluoxetine. akathisia, and suicidality: is there a causal connection’? Archives of General Psychiatry. 1992; 49: 580–581.

    CAS  PubMed  Google Scholar 

  • Wolfersdorf M. The value of psychotropic drugs in treatment of suicidal behavior. Psychiatrische Praxis, 1992; 19: 100–107.

    CAS  PubMed  Google Scholar 

Download references

Authors
  1. Fabrizio Schifano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Diego De Leo
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychogeriatrics, Institute of Neurology and Psychiatry, University of Padua, Italy

    D. De Leo

  2. Department of Clinical Psychology, Institute of Psychiatry, University of Würzburg, Germany

    A. Schmidtke

  3. Community Mental Health Center, Leiden and Municipal Health Authority, Rotterdam, The Netherlands

    R. F. W. Diekstra

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Kluwer Academic Publishers

About this chapter

Cite this chapter

Schifano, F., De Leo, D. (1998). Pharmacological Treatment of Suicidal Behavior. In: De Leo, D., Schmidtke, A., Diekstra, R.F.W. (eds) Suicide Prevention. Springer, Dordrecht. https://doi.org/10.1007/0-306-47210-4_21

Download citation

  • DOI: https://doi.org/10.1007/0-306-47210-4_21

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-7923-4468-1

  • Online ISBN: 978-0-306-47210-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation